Precision Oncology Patient Innovation Awards

Eligibility Criteria

Applications will be accepted from 1 NGO that is a patient organization and 1 NGO that is a healthcare institution. Applications from individuals will not be allowed.
The grant amount requested in funding cannot exceed 25% of an organization’s overall funding. Applicants will be accepted from any region or country unless prohibited by national laws
Programs must be nonpromotional and should not include mention of any particular medicine but may refer to class of treatment
Each organization may submit only one entry
Submissions must be received no later than 12:00 AM Eastern Standard Time on June 16, 2023
Submissions are restricted to the application form and may not include additional attachments

Apply for the Precision Oncology Patient Innovation Awards

Applications that do not serve or plan to address specific needs related to the cancer community will not be reviewed
Applicants may not submit a grant application relating to a program for which funding is already being provided by Bayer
Employees of Bayer, VOZ, and other vendors or members of the immediate family of any such persons are not eligible
Review panel members and their organizations are not eligible
The review panel reserves the right to exclude submissions that could be perceived as being too closely aligned with either themselves or Bayer and its interests
Payment will not be made to individuals; for healthcare professionals, payment can be made to an institution. Individuals, or other companies interested in applying will need to partner with a non-profit or other organization
Funding provided to the selected applicant will not cover indirect costs

Apply for the Precision Oncology Patient Innovation Awards

The review panel will select two programs to receive a grant of $50,000 USD each or the equivalent in the applicants' local currency
The review panel’s decision will be final, and no appeals will be permitted
Successful applicants will receive a grant request letter and be asked to countersign a copy of Bayer’s Terms and Conditions before receiving the funds. (These relate to the provision of unrestricted grants for scientific or educational use.)
Proposed initiatives should be initiated within 6 months of receiving funds
Grant recipients should provide a full report 1 year after receiving funds and/or at the end of the program, and describe what the project achieved. If special dispensation is required, this should be agreed upon at the start
Successful applicant names/institutions will be published on this website and publicly disclosed information will be shared with the cancer community

See the Program’s Past Winners